In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections

Diagnostic Microbiology and Infectious Disease
Thomas R FritscheRonald N Jones

Abstract

Tigecycline is a novel 9-t-butylglycylamido derivative of minocycline that has demonstrated activity against a variety of bacterial pathogens, including resistant isolates, during preclinical studies. In vitro activities of tigecycline and comparators were tested against 11,859 recent (2000 and 2002) bacterial strains recovered from patients in 29 countries with community-acquired respiratory tract disease (3,317 gram-positive and -negative strains) and skin and soft tissue infections (8,542 gram-positive strains). All oxacillin-susceptible and -resistant Staphylococcus aureus (5,077 strains; tigecycline MIC(90), 0.5 microg/mL) and coagulase-negative staphylococci (1,432 strains; MIC(90), 0.5 microg/mL), penicillin-susceptible and -resistant Streptococcus pneumoniae (1,585 strains; MIC(90), < or =0.25 microg/mL), viridans group streptococci (212 strains; MIC(90), < or =0.25-0.5 microg/mL), vancomycin-susceptible and -resistant enterococci (1,416 strains; MIC(90), 0.25-0.5 microg/mL), beta-haemolytic streptococci (405 strains; MIC(90), < or =0.25 microg/mL), beta-lactamase positive and negative Haemophilus influenzae (1,220 strains; MIC(90), 1 microg/mL), Moraxella catarrhalis (495 strains; MIC(90), 0.25 microg/mL), and Neisseri...Continue Reading

References

Jul 18, 2000·Antimicrobial Agents and Chemotherapy·H W BoucherG M Eliopoulos
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·E J GoldsteinK Tyrrell
Jan 5, 2002·Current Opinion in Pharmacology·I Chopra
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Carmen BetriuUNKNOWN Spanish Group of Tigecycline
Nov 29, 2002·Current Drug Targets. Infectious Disorders·A Canu, R Leclercq
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
May 30, 2003·The Annals of Pharmacotherapy·Alan H MutnickRonald N Jones
Nov 5, 2003·Diagnostic Microbiology and Infectious Disease·Kathleen A RuggeroJohn P Quinn
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Fred C TenoverBülent Bozdogan

❮ Previous
Next ❯

Citations

Nov 30, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G M Eliopoulos
Feb 25, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KreskenUNKNOWN Study Group
May 10, 2005·Diagnostic Microbiology and Infectious Disease·Paul R Rhomberg, Ronald N Jones
May 12, 2005·International Journal of Antimicrobial Agents·John E ConteElisabeth Zurlinden
Dec 16, 2009·International Journal of Antimicrobial Agents·Paolo A Grossi
Feb 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stan Deresinski
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia A BradfordPeter J Petersen
Dec 20, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Nai-Cheng ChengCheng-Yi Liu
Sep 19, 2007·Antimicrobial Agents and Chemotherapy·Catherine L ClarkPeter C Appelbaum
Dec 10, 2008·Antimicrobial Agents and Chemotherapy·G A Pankuch, P C Appelbaum
Jan 11, 2007·Antimicrobial Agents and Chemotherapy·Radosław IzdebskiWaleria Hryniewicz
Jun 28, 2005·Drugs·Ethan Rubinstein, David Vaughan
Jan 31, 2006·Expert Review of Anti-infective Therapy·George G ZhanelDaryl J Hoban
Jan 31, 2008·Expert Opinion on Investigational Drugs·Garyphallia Poulakou, Helen Giamarellou
Jul 30, 2005·Expert Opinion on Investigational Drugs·Holly L Hoffman-RobertsIsaac F Mitropoulos
Sep 22, 2009·The Journal of Infection·George M Eliopoulos
Jun 9, 2009·Diagnostic Microbiology and Infectious Disease·George A Pankey, Deborah S Ashcraft
Jul 26, 2006·Pharmacotherapy·Warren E Rose, Michael J Rybak
Sep 20, 2006·Clinical Therapeutics·Thien-Ly DoanPaul F Riska
Apr 25, 2006·Diagnostic Microbiology and Infectious Disease·Kwan Soo KoNam Yong Lee
Aug 18, 2005·Diagnostic Microbiology and Infectious Disease·Helio S SaderThomas R Fritsche
Aug 18, 2005·Diagnostic Microbiology and Infectious Disease·Helio S SaderThomas R Fritsche
Aug 18, 2005·Diagnostic Microbiology and Infectious Disease·Thomas R FritscheRonald N Jones
Oct 27, 2005·The Journal of Dermatological Treatment·Noah Scheinfeld
Dec 3, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E Bouza
Mar 16, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P Hawkey, R Finch
Dec 31, 2014·Antimicrobial Agents and Chemotherapy·Qian ZhangJing Zhou
Jan 6, 2006·Obstetrics and Gynecology
Oct 24, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Fuat H SanerChristoph E Broelsch
Jun 23, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nishaminy Kasbekar
Jul 26, 2005·The Journal of Antimicrobial Chemotherapy·George A Pankey
Aug 27, 2005·The Journal of Antimicrobial Chemotherapy·David M Livermore
Jan 18, 2006·The Journal of Antimicrobial Chemotherapy·Göran KronvallLennart E Nilsson
Jun 23, 2006·Intensive Care Medicine·Robert J CameronPeter J Rye
Aug 30, 2020·Journal of Clinical Pharmacy and Therapeutics·Qian ZhangJing Zhou
Mar 26, 2005·The Journal of Antimicrobial Chemotherapy·C BetriuJ J Picazo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.